Labcorp Net Profit Margin 2010-2024 | LH
Current and historical net profit margin for Labcorp (LH) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Labcorp net profit margin for the three months ending March 31, 2024 was .
| Labcorp Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-03-31 |
$11.56B |
$0.43B |
3.75% |
| 2023-12-31 |
$12.16B |
$0.42B |
3.44% |
| 2023-09-30 |
$12.04B |
$0.66B |
5.49% |
| 2023-06-30 |
$11.85B |
$0.83B |
7.01% |
| 2023-03-31 |
$11.74B |
$1.00B |
8.52% |
| 2022-12-31 |
$11.87B |
$1.28B |
10.79% |
| 2022-09-30 |
$10.76B |
$1.76B |
16.33% |
| 2022-06-30 |
$11.96B |
$1.99B |
16.65% |
| 2022-03-31 |
$12.88B |
$2.10B |
16.30% |
| 2021-12-31 |
$13.14B |
$2.38B |
18.09% |
| 2021-09-30 |
$16.56B |
$2.76B |
16.68% |
| 2021-06-30 |
$16.39B |
$2.88B |
17.56% |
| 2021-03-31 |
$15.32B |
$2.64B |
17.26% |
| 2020-12-31 |
$13.98B |
$1.56B |
11.13% |
| 2020-09-30 |
$12.44B |
$0.85B |
6.79% |
| 2020-06-30 |
$11.48B |
$0.36B |
3.16% |
| 2020-03-31 |
$11.59B |
$0.32B |
2.77% |
| 2019-12-31 |
$11.56B |
$0.82B |
7.13% |
| 2019-09-30 |
$11.39B |
$0.76B |
6.63% |
| 2019-06-30 |
$11.29B |
$0.85B |
7.55% |
| 2019-03-31 |
$11.28B |
$0.90B |
7.95% |
| 2018-12-31 |
$11.33B |
$0.88B |
7.80% |
| 2018-09-30 |
$11.29B |
$1.41B |
12.52% |
| 2018-06-30 |
$11.08B |
$1.27B |
11.44% |
| 2018-03-31 |
$10.74B |
$1.22B |
11.34% |
| 2017-12-31 |
$10.31B |
$1.23B |
11.91% |
| 2017-09-30 |
$9.90B |
$0.70B |
7.11% |
| 2017-06-30 |
$9.70B |
$0.71B |
7.34% |
| 2017-03-31 |
$9.60B |
$0.73B |
7.61% |
| 2016-12-31 |
$9.55B |
$0.71B |
7.45% |
| 2016-09-30 |
$9.52B |
$0.66B |
6.92% |
| 2016-06-30 |
$9.42B |
$0.63B |
6.72% |
| 2016-03-31 |
$9.26B |
$0.60B |
6.47% |
| 2015-12-31 |
$8.68B |
$0.44B |
5.05% |
| 2015-09-30 |
$7.89B |
$0.45B |
5.68% |
| 2015-06-30 |
$7.13B |
$0.43B |
6.03% |
| 2015-03-31 |
$6.37B |
$0.40B |
6.29% |
| 2014-12-31 |
$6.01B |
$0.51B |
8.50% |
| 2014-09-30 |
$5.94B |
$0.52B |
8.71% |
| 2014-06-30 |
$5.85B |
$0.53B |
9.03% |
| 2014-03-31 |
$5.80B |
$0.54B |
9.30% |
| 2013-12-31 |
$5.81B |
$0.57B |
9.87% |
| 2013-09-30 |
$5.78B |
$0.57B |
9.82% |
| 2013-06-30 |
$5.73B |
$0.57B |
9.89% |
| 2013-03-31 |
$5.69B |
$0.57B |
9.99% |
| 2012-12-31 |
$5.67B |
$0.58B |
10.28% |
| 2012-09-30 |
$5.63B |
$0.60B |
10.62% |
| 2012-06-30 |
$5.62B |
$0.58B |
10.40% |
| 2012-03-31 |
$5.60B |
$0.55B |
9.90% |
| 2011-12-31 |
$5.54B |
$0.52B |
9.36% |
| 2011-09-30 |
$5.47B |
$0.52B |
9.43% |
| 2011-06-30 |
$5.34B |
$0.52B |
9.77% |
| 2011-03-31 |
$5.18B |
$0.55B |
10.68% |
| 2010-12-31 |
$5.00B |
$0.56B |
11.17% |
| 2010-09-30 |
$4.87B |
$0.57B |
11.69% |
| 2010-06-30 |
$4.78B |
$0.56B |
11.73% |
| 2010-03-31 |
$4.73B |
$0.54B |
11.47% |
| 2009-12-31 |
$4.70B |
$0.54B |
11.57% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.691B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
